Key Takeaways Tilray Q4 EPS beat estimates but sales missed, with both declining year over year.Fiscal 2025 revenues hit $821M, led by 70% sales from non-cannabis segments.Cannabis sales fell 9% in 2025, offset by 19% growth in international cannabis sales.On Monday, Canada-based Tilray Brands (TLRY) announced its fourth-quarter results for fiscal 2025 (year ending May 2025). While earnings beat our estimates, sales fell short of expectations. Both numbers declined when compared to the year-ago quarter.Adju ...